Alex Zhavoronkov

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper et al. · Nature Biotechnology · 2019 · 1.5K citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Artur Kadurin, Sergey Nikolenko, Kuzma Khrabrov et al. · Molecular Pharmaceutics · 2017 · 614 citations

Pharmacy, Medicinal Chemistry, Drug Design +15

Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data

Alexander Aliper, Sergey Plis, Artem V. Artemov et al. · Molecular Pharmaceutics · 2016 · 605 citations · Full text

Life Sciences, Bioinformatics, Pharmacology +12

Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare

Polina Mamoshina, Lucy O. Ojomoko, Yury Yanovich et al. · Oncotarget · 2017 · 472 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Reinforced Adversarial Neural Computer for <i>de Novo</i> Molecular Design

Arip Asadulaev, Yan A. Ivanenkov, Vladimir Aladinskiy et al. · Journal of Chemical Information and Modeling · 2018 · 387 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +12